MwanzoNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Bei iliyotangulia
$ 1.48
Bei za siku
$ 1.42 - $ 1.60
Bei za mwaka
$ 1.29 - $ 99.75
Thamani ya kampuni katika soko
38.40M USD
Wastani wa hisa zilizouzwa
elfu 447.80
Uwiano wa bei na mapato
0.55
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 521.00 | -78.66% |
Matumizi ya uendeshaji wa biashara | 1.21M | -28.89% |
Mapato halisi | -1.29M | -6.68% |
Kiwango cha faida halisi | -248.18 | — |
Mapato kwa kila hisa | — | — |
EBITDA | -1.17M | 31.23% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.31M | 197.55% |
Jumla ya mali | 3.49M | -10.06% |
Jumla ya dhima | 1.85M | -33.94% |
Jumla ya hisa | 1.63M | — |
hisa zilizosalia | 25.20M | — |
Uwiano wa bei na thamani | -0.66 | — |
Faida inayotokana na mali | -56.21% | — |
Faida inayotokana mtaji | -74.07% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.29M | -6.68% |
Pesa kutokana na shughuli | -1.80M | 12.71% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | -1.32M | -163.17% |
Mabadiliko halisi ya pesa taslimu | -3.12M | -12,096.15% |
Mtiririko huru wa pesa | -1.22M | 35.34% |
Kuhusu
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Ilianzishwa
2000
Makao Makuu
Tovuti
Wafanyakazi
14
